More subsequent studies have also demonstrated that METTL3 is significantly upregulated in hepatocellular carcinoma (HCC) (20), colorectal cancer (CRC) (18), retinoblastoma (RB) (20), and multiple solid tumors. Here, METTL3 is linked to hepatocellular carcinoma.